JPWO2021014166A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021014166A5 JPWO2021014166A5 JP2022504089A JP2022504089A JPWO2021014166A5 JP WO2021014166 A5 JPWO2021014166 A5 JP WO2021014166A5 JP 2022504089 A JP2022504089 A JP 2022504089A JP 2022504089 A JP2022504089 A JP 2022504089A JP WO2021014166 A5 JPWO2021014166 A5 JP WO2021014166A5
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- compound
- carboxamide
- acetyl
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1910607.9 | 2019-07-24 | ||
| GBGB1910607.9A GB201910607D0 (en) | 2019-07-24 | 2019-07-24 | Compounds |
| GBGB2005739.4A GB202005739D0 (en) | 2020-04-20 | 2020-04-20 | Compounds |
| GB2005739.4 | 2020-04-20 | ||
| PCT/GB2020/051778 WO2021014166A1 (en) | 2019-07-24 | 2020-07-24 | Pyridine derivatives as tmem16a modulators for use in the treatment of respiratory conditions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022541311A JP2022541311A (ja) | 2022-09-22 |
| JPWO2021014166A5 true JPWO2021014166A5 (hr) | 2023-07-25 |
Family
ID=71948615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022504089A Pending JP2022541311A (ja) | 2019-07-24 | 2020-07-24 | 呼吸器症状の治療における使用のためのｔｍｅｍ１６ａモジュレータとしてのピリジン誘導体 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20220235006A1 (hr) |
| EP (1) | EP4003516A1 (hr) |
| JP (1) | JP2022541311A (hr) |
| KR (1) | KR20220063162A (hr) |
| CN (1) | CN114616226A (hr) |
| AU (1) | AU2020317036A1 (hr) |
| BR (1) | BR112022001164A2 (hr) |
| CA (1) | CA3145120A1 (hr) |
| CL (1) | CL2022000147A1 (hr) |
| CO (1) | CO2022002022A2 (hr) |
| CR (1) | CR20220072A (hr) |
| IL (1) | IL290035A (hr) |
| MX (1) | MX2022000841A (hr) |
| PE (1) | PE20221441A1 (hr) |
| WO (1) | WO2021014166A1 (hr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2022541311A (ja) * | 2019-07-24 | 2022-09-22 | ティーエムイーエム１６エー リミテッド | 呼吸器症状の治療における使用のためのｔｍｅｍ１６ａモジュレータとしてのピリジン誘導体 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005042524A1 (en) * | 2003-10-30 | 2005-05-12 | Virochem Pharma Inc. | Pyridine carboxamide and methods for inhibiting hiv integrase |
| US11358947B2 (en) * | 2017-04-17 | 2022-06-14 | The Regents Of The University Of California | Substituted 2-acylamino-cycloalkylthiophene-3-carboxylic acid arylamides as inhibitors of calcium-activated chloride channel TMEM16A |
| GB201801355D0 (en) * | 2018-01-26 | 2018-03-14 | Enterprise Therapeutics Ltd | Compounds |
| JP2022541311A (ja) * | 2019-07-24 | 2022-09-22 | ティーエムイーエム１６エー リミテッド | 呼吸器症状の治療における使用のためのｔｍｅｍ１６ａモジュレータとしてのピリジン誘導体 |
-
2020
- 2020-07-24 JP JP2022504089A patent/JP2022541311A/ja active Pending
- 2020-07-24 CA CA3145120A patent/CA3145120A1/en active Pending
- 2020-07-24 PE PE2022000119A patent/PE20221441A1/es unknown
- 2020-07-24 WO PCT/GB2020/051778 patent/WO2021014166A1/en active Application Filing
- 2020-07-24 CN CN202080053192.6A patent/CN114616226A/zh active Pending
- 2020-07-24 EP EP20751234.4A patent/EP4003516A1/en active Pending
- 2020-07-24 KR KR1020227006371A patent/KR20220063162A/ko active Search and Examination
- 2020-07-24 BR BR112022001164A patent/BR112022001164A2/pt unknown
- 2020-07-24 MX MX2022000841A patent/MX2022000841A/es unknown
- 2020-07-24 CR CR20220072A patent/CR20220072A/es unknown
- 2020-07-24 AU AU2020317036A patent/AU2020317036A1/en not_active Abandoned
-
2022
- 2022-01-21 CL CL2022000147A patent/CL2022000147A1/es unknown
- 2022-01-21 US US17/581,504 patent/US20220235006A1/en active Pending
- 2022-01-23 IL IL290035A patent/IL290035A/en unknown
- 2022-02-24 CO CONC2022/0002022A patent/CO2022002022A2/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2016202676B2 (en) | Polycyclic antagonists of lysophosphatidic acid receptors | |
| JP2006501295A5 (hr) | ||
| RU2361860C2 (ru) | Новые замещенные 3-сера-индолы | |
| JP2019038820A5 (hr) | ||
| JP2004502670A5 (hr) | ||
| RU2007101236A (ru) | Новые гидантоиновые производные для лечения обструктивных заболеваний дыхательных путей | |
| RU2009102278A (ru) | Модуляторы рецептора s1p для лечения рассеянного склероза | |
| JP2007502806A5 (hr) | ||
| JP2014530900A5 (hr) | ||
| RU2004117887A (ru) | Ариланилиновые агонисты бета2 адренергических рецепторов | |
| RU2018136888A (ru) | Нафтиридины в качестве антагонистов интегрина | |
| RU2012125372A (ru) | Производные пиразола в качестве ингибиторов 11-бета-hsd1 | |
| RU2010126063A (ru) | Производные 4-(2-амино-1-гидроксиэтил)фенола как агонисты в2 адренергического рецептора | |
| JP2011506469A5 (hr) | ||
| RU2014148316A (ru) | Производные 1-фенил-2-пиридинил-алкиловых спиртов в качестве ингибиторов фосфодиэстеразы | |
| RU2013130879A (ru) | Производные оксазолилметилового эфира в качестве агонистов рецептора alx | |
| JP2004524345A5 (hr) | ||
| JP2017509694A5 (hr) | ||
| US20220324811A1 (en) | 1,3-substituted cyclobutyl derivatives and uses thereof | |
| JP2020111571A5 (hr) | ||
| JPWO2019145726A5 (hr) | ||
| JPWO2021014166A5 (hr) | ||
| MXPA02001740A (es) | Uso de bis-sulfonamidas para producir medicinas para la profilaxis o tratamiento de hiperlipidemia. | |
| JP2007509052A5 (hr) | ||
| JP4045099B2 (ja) | ２０−ｈｅｔｅ産生酵素阻害剤 |